abbreviationS ACDF = anterior cervical discectomy and fusion; AE = adverse event; AP = anteroposterior; ASD = adjacent-segment disease; BMI = body mass index; COI = conflict of interest; COR = center of rotation; cTDR = cervical total disc replacement; FJD = facet joint degeneration; HO = heterotopic ossification; NDI = Neck Disability Index; RCT = randomized controlled trial; ROM = range of motion; VAS = visual analog scale. obJeCtive Recent studies have described encouraging outcomes after cervical total disc replacement (cTDR), but there are also critical debates regarding the long-term effects of heterotopic ossification (HO) and the prevalence of adjacent-level degeneration. The aim in this paper was to provide 4-year clinical and radiographic outcome results on the activ C disc prosthesis. MethoDS A total of 200 subjects underwent single-level activ C (Aesculap AG) implantation between C-3 and C-7 for the treatment of symptomatic degenerative disc disease. Clinical and radiographic assessments were performed preoperatively, intraoperatively, at discharge, and again at 6 weeks, 6 months, 1 year, 2 years, and 4 years. Radiographic evaluations were done by an independent core laboratory using a specific software for quantitative motion analysis. reSUltS Neck Disability Index (NDI) and visual analog scale (VAS) score for neck and arm pain decreased significantly from baseline to the 4-year follow-up. The mean improvement for NDI was 20, for VAS severity and frequency of neck pain 26.4 and 28, and for VAS severity and frequency of arm pain 30.7 and 35.1, respectively. The neurological situation improved for the majority of patients (86.4%); 76.1% of cases were asymptomatic. Subsequent surgical interventions were reported in 7% of the cases, including device removals in 3%. In 2.5% a subsidence greater than 3 mm was recorded; 1 of these cases also had a migration greater than 3 mm. No device displacement, expulsion, disassembly, loose or fractured device, osteolysis, or facet joint degeneration at the index level was observed. Segmental lordotic alignment changed from -2.4° preoperatively to -6.2° at 4 years, and postoperative height was maintained during the follow-up. Advanced HO (Grade III and IV) was present in 27.1% of the cases; 82.4% showed segmental mobility. A progression of radiographic adjacent-segment degeneration occurred in 28.2%, but only 4.5% required surgical treatment. ConClUSionS The activ C is a safe and effective device for cervical disc replacement confirming the encouraging results after cTDR.
A nterior cervical discectomy and fusion (ACDF) is a standard technique for the treatment of cervical degenerative disc disease that is unresponsive to conservative therapy. 14, 27, 49 Despite its success, adjacent-segment overload has been reported by several authors, 3, 8, 23, 24, 26, 30, 32, 37 supported by in vitro demonstration of increased motion and/or intradiscal pressure at adjacent levels. [18] [19] [20] 44 cTDR was developed to preserve motion, to relieve the adjacent levels, and consequently to decrease the risk for adjacent-segment disease (ASD). 19, 46 Today, several devices for cTDR with different design concepts are on the market, some of them with clinical and radiographic mid-to long-term results. 1, 11, 13, 17, 22, 41, 47, 52, 57, 59 Various randomized controlled trials have indicated equivalence or even superiority of cTDR in some clinical aspects compared with ACDF. 9, 25, 36, 40, 54 However, there remains critical debate on cTDR mainly regarding indication, costs, and heterotopic ossification (HO). 4,10,12,34,38,41,50,52, 57,58 HO may not affect clinical outcome 5, 33, 38, 52, 57 or be less relevant in the absence of clinical symptoms, 6 ,28 but advanced HO potentially compromises segmental mobility with an unknown impact on sagittal profile, long-term clinical results, and ASD.
With this prospective, single-arm, multicenter study the clinical and radiographic 4-year results after cTDR are assessed.
Methods
Two hundred patients were enrolled by 11 study sites according to the criteria of Table 1 between January 2007 and December 2009. Subjects received single-level cTDR (activ C, Aesculap AG, Fig. 1 ) and underwent follow-up for 4 years. The study received a central and local ethics approval for each study center, and all subjects gave written consent prior to study enrollment (Clinical trial registration no.: NCT02492724 [clinicaltrials.gov]).
Clinical outcomes included improvement of Neck Disability Index (NDI) and visual analog scale (VAS) scores regarding the severity and frequency of neck and arm pain from baseline to 4-year follow-up, neurological examinations (manual muscle test, sensory and reflex assessments), the patient's view on the success of surgery, complications, and subsequent surgical interventions. The NDI was used according to the original publication by Vernon et al. 55 The score obtained was multiplied by 2 to produce a percentage score.
All radiographic evaluations were performed by an independent core laboratory that analyzed digital anteroposterior (AP), lateral, and dynamic (flexion/extension) images. Measures were made using validated quantitative motion analysis software (QMA, Medical Metrics Inc.), 21, 45, 48, 53 and qualitative assessments were performed by an experienced radiologist. Radiographic parameters included segmental lordosis, C2-7 angle, average disc height at index level, radiolucency at the bone-implant interface, HO according to Mehren et al. 38 conforming to McAfee et al., 35 osteolysis, facet joint degeneration (FJD), device condition and placement, subsidence, migration, range of motion (ROM), translation, and center of rotation (COR) in the x and y axes at the index level. Furthermore, ASD above and below the index level was observed. ASD was identified if a subject's grading on disc degeneration and/or FJD (both Grade 0 to 4 according to Kellgren 31 and Côté et al. 16 ) was ≥ Grade 2 and minimum 1 grade higher than preoperatively, any new instability occurred (≥ 3.5 mm translation and/or ≥ 11° rotational difference to neighboring segments), and/or any instrumentation was added. Magnification is corrected by a calibration ring. Due to the lack of a direct control group, we compared the study results with published control groups (cTDR and ACDF) with 4-to 6-year results. These studies included 4 randomized controlled trials (RCTs) 15, 26, 46, 53, 56 comparing cTDR and ACDF plus 1 paper discussing 4-year cTDR results with special regard to HO.
implant and Surgery
The activ C cervical disc prosthesis is a semiconstrained implant in a "ball and socket" design, with anatomically shaped prosthesis plates in 6 sizes and heights from 5 to 7 mm, coated with osteointegrative plasma-sprayed pure titanium (Plasmapore, Aesculap AG). A combination of spikes and keel allows for primary stability. All implants incorporate a lordotic angle of 3°. Natural motion pattern is implemented through the inlay/prosthesis shape and its adaption to the facet joints. Standard and flat designs address light or moderate degeneration.
Surgery was performed by a total of 24 surgeons in 11 centers, with up to 4 surgeons in 1 center. For detailed information on case distribution by center and surgeon see Table 2 . Following a standard right-or left-sided anterolateral approach and after total anterior discectomy and decompression the implant bed was prepared, and the implant size and height was tested by trial components. The preparation of an AP slot into the caudal vertebral body allows en bloc implantation, avoiding over-distraction. Postoperative care was handled according to the center's standard procedures. The physical initial and follow-up examinations were done by either the investigators or other surgeons at the hospital.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics (version 21). Comparisons for means (pre-vs postoperative results) used a nonparametric Wilcoxon signed-rank test; for independent groups a nonparametric Mann-Whitney U-test was used. Statistical significance is assumed at p < 0.05.
results

Patient Demographics
One hundred twenty-eight of 200 patients (64%) received a standard implant design and 72 (36%) a flat implant design (for demographics see Table 3 ). No statistically significant differences were found between the groups regarding age, sex, body mass index (BMI), duration of symptoms, and level of surgery (unpaired t-test, chi-square test).
intraoperative Details and Discharge
The mean operation time was 78 ± 25 minutes, and approaches were left-sided in 88.4% of patients and rightsided in 11.6%. The independent reviewer reported "ideal lateral placement" for all implantations; no oblique implant position or axial rotation occurred. The appropriate implant size was chosen in 98.0% of cases (195/199), and 
Postoperative outcome
Four-year results are available for 168 of 193 patients (87%) who were expected to have results at 4 years. Seven patients were not able to complete the study for the following reasons: one subject died 3 years postoperatively but this death was not related to the device or procedure, and 6 subjects underwent device removal or supplemental fixation at the index level prior to their 4-year examination (for more information on these 7 cases see Adverse Events and Secondary Surgical Interventions below).
Clinical outcome
All patient self-administered outcome measures showed statistically significant (p < 0.001, Wilcoxon signed-rank test) and clinically important 50, 51 improvements from baseline to the 4-year follow-up (Fig. 2) . Mean improvement (± SD) for NDI was 20 ± 21 (n = 156), for VAS severity of neck pain 26.4 (± 33.9) (n = 158), for VAS frequency of neck pain 28 ± 37.8 (n = 158), for VAS severity of arm pain 30.7 ± 34.8 (n = 158), and for VAS frequency of arm pain 35.1 ± 37.4 (n = 158) (Table 4) .
Preoperatively, 34% (68/200) of all cases had a combined sensory and motor deficit, 11.5% (23/200), a motor deficit, and 35.5% (71/200) a sensory deficit. Four years postoperatively, the neurological situation has improved for the majority of patients (86.4%) with 76.1% (118/155) asymptomatic cases. In 8.4% (13/154) the neurological deficit continued and in 5.2% (8/154) it deteriorated compared with the preoperative situation (motor deficit in 2, combined sensory and motor deficit in 6). In terms of patients' personal feelings on surgery success at 4 years, 133 of 157 patients (84.7%) responded "excellent or good result," 19 of 157 (12.1%) "fair result," and 5 of 157 (3.2%) "poor result."
Clinical outcome results of control groups are summarized in Table 5 .
adverse events
Surgery-related complications occurred in 2 cases (1%: 1 excessive perioperative hemorrhage and 1 postoperative hematoma). For completeness of the picture, systemic complications were also recorded, occurring in 8 cases (carpal tunnel syndrome in 3, and sulcus ulnaris syndrome, shoulder pain, multiple pain, stroke, and Parkinson disease in 1 case each), 26 postoperative complications occurred in 21 patients (10.5%: persistent pain in 12, dysphagia in 1, neurological symptoms in 13 patients), and 12 adjacent-level-related complications in 9 cases (4.5%: pain in 3, symptomatic adjacent-level degeneration in 8, and neurological symptoms in 1 case). Six possibly devicerelated complications were seen in 5 patients (2.5%, 5 with subsidence > 3 mm, including 1 with migration > 3 mm).
Secondary Surgical interventions
Fifteen secondary surgical interventions on the cervical spine were reported in 14 subjects (7%): the investigational device was removed in 6 cases (3%), 1 followed by a 2-level fusion due to ASD was performed in 1 case, and 9 additional instrumentations were performed in 8 cases, one of them at index level. Three cases with other surgeries occurred, but not in the cervical spine.
In 3 cases implant removal was due to persistent radiculopathy, which recovered in 1 case after cTDR reimplantation, but did not in 2 cases after secondary fusion surgery. One patient who complained of postoperative neck pain and dysphagia received a smaller activ C implant and recovered completely afterward. In 1 patient caudal subsidence and posterior migration of more than 3 mm was diagnosed at final follow-up. Although the patient was pain free without any neurological symptoms, the cTDR was removed as a precautionary measure 5 years after implantation and subsequently fused. Another cTDR was replaced by 2-level fusion. In this case the initial decision for a single-level treatment was wrong. The patient suffered from pain progression caused by ASD and recovered after fusion surgery. As mentioned above, ASD was also the reason for 9 additional instrumentations in 8 subjects. Two patients received a second cTDR, and 6 subjects had fusion in an adjacent segment. In one of these subjects the initial adjacent-segment fusion was followed by a bilevel fusion that included the index level.
A systematic review of adverse events (AEs) and secondary surgeries of control groups is summarized in Table 6 .
radiological results at the index level
Four years postoperatively, independent radiographic measurements show a more lordotic alignment for segmental lordosis (-6.2° vs -2.4° preoperatively) and C2-7 angle (-8.7° vs -6.4° preoperatively) (p < 0.001 and p < 0.05, respectively, Wilcoxon signed-rank test). The average disc height at the index level changed from 3.7 mm preoperatively to 5.6 mm (p < 0.001, Wilcoxon signedrank test). Loss of mean disc height during the postoperative follow-up was clinically irrelevant, with 0.2 mm between 6 weeks and 4 years. Seven radiolucencies along the implant-bone interface were detected; 3 of them were mild (< 25%), 4 moderate (25%-50%), and none resulted in implant loosening. Four years after surgery, Grade 0-II HO was recorded in 110 of 151 (72.8%), Grade III in 21 of 151 (13.9%), and Grade IV in 20 of 151 (13.2%) cases. No statistically significant differences were found between cases with Grade 0-II HO and Grade III-IV HO regarding NDI and VAS neck and arm pain (Mann-Whitney Utest, p > 0.05). The independent reviewer identified no lateral device displacement, disassembled, loose or fractured device, device expulsion, osteolysis, or FJD at the index level. Figure 3 shows the radiological progression of HO in 1 patient with a final Grade IV after 4 years. Segmental ROM changed from 9.3° preoperatively to 6.5° at 4 years (p < 0.001, Wilcoxon signed-rank test). Motion of at least 2° was seen in 82.4% of subjects. Translation was 0.9 mm prior to surgery and 0.6 mm after 4 years (p < 0.001, Wilcoxon signed-rank test). The COR in the AP direction (CORx) changed from -0.8 mm preoperatively to 0.1 mm 4 years postoperatively (p < 0.001, Wilcoxon signed-rank test). CORx moved from a position posterior to the midpoint of the inferior vertebra to a position slightly anterior to it. In the cranial-caudal direction, the COR (CORy) changed from 2.3 mm preoperatively to 1.0 mm at 4 years (p < 0.001, Wilcoxon signed-rank test), which corresponds to a cranial shift. For more detailed information on radiographic results, see Table 7 .
aSD Four years postoperatively, 15.3% of cases (23/150) showed radiographic progression of ASD above and 15.4% (23/149) below the index level. Four subjects showed degeneration above and below; thus, radiographic progression of ASD was 28.2% (42/149 ). This includes symptomatic and asymptomatic cases. Most cases (73.9%; 17/23) with ASD above the index level showed a new radiographic disc degeneration compared with the preoperative situation; no patient showed a radiographic progression of FJD. In 1 case (4.3%) a progressive instability caused ASD, and 5 patients (21.7%) underwent adjacent-segment surgery. Similarly, below the index level most cases (82.6%; 19/23) showed a radiographic progression of disc degeneration, none had a radiographic progression of FJD or instability, and 4 (17.4%) underwent adjacent-segment surgery. Principally, the decision for reoperation as a result of ASD was done individually if radicular pain and/or neurological deficits occurred in combination with corresponding radiographically confirmed ASD. The rate of surgery due to ASD for the entire study population was 4.5% (9/200); no distant segment surgery was performed.
ASD and HO results of control groups are summarized in Table 6 .
Discussion
Although ACDF has been considered the gold-standard surgery for the treatment of cervical disc degeneration for the last few decades, several RCTs have reported equivalent or superior clinical outcomes of cTDR compared with ACDF. 25, 36, 40, 54 A recent Cochrane Review came to a similar conclusion, 9 but it claims that mid-and long-term follow-up periods are needed to assess the clinical benefit of cTDR.
In this study NDI as well as VAS results on neck and arm pain improved significantly after 4 years. 29, 43 As shown in Table 5 , clinical results are within the range of the cTDR and ACDF control groups, with the exception of VAS arm pain, which is slightly higher in our patients. Also, neurological success is comparable to the cTDR control groups, but slightly better than in ACDF. The range of surgery-related AEs differs, with 2.4%-11.7% for cTDR and 0.0%-20.8% for ACDF, which is probably due to inhomogeneous definitions used. However, our study results are within the range of both groups. The same applies to device failure and secondary surgeries at the index level. 1, 11, 13, 17, 22, 47, 52, 59 Cervical and segmental lordosis improved versus the preoperative situation, ROM decreased from 9.3° to 6.5° at 4-year-follow-up, and in 82.4% of patients a segmental motion of at least 2° was maintained. A similar tendency was reported by Goffin et al. 22 on the Bryan disc with an ROM reduction from 9.3° preoperatively to 7.3° 4 years postoperatively and a motion ≥ 2° in 83.1% of single-level procedures, whereas Sasso et al. 47 did not report a rate of motion maintenance in their extended investigational device exemption trial on the Bryan disc, but observed an improvement of ROM from 6.5° preoperatively to 8.5° 4 years postoperatively. Five-year results in the SWISSspine registry 1 showed mobile segments (> 2°) in 88.2% (332 patients) with an average ROM in these mobile segments of 10.2°.
HO after cTDR is a matter of debate, as it counteracts motion preservation. Our study results show advanced Grade III HO in 13.9% of cases and Grade IV HO in 13.2% of cases 4 years after cTDR. Using the same classification system as was used for this study, Suchomel et al. 52 observed 45% of cases with HO Grade III and 18% with Grade IV at 4 years. Table 6 shows that 2 cTDR control groups had lower rates for bridging bone or Grade IV HO (3.2% and 8.3%), but the other 2 studies reported even higher rates (17.0% and 18.0%).
Further literature also shows wide ranges of HO Grade IV (fusion) rates, between less than 1% after 1 year and 2.9% to 18.5% after 2 years, up to 60% after 5 years. 7, 28, 39, 40, 42, 50 Chen et al. 12 report a pooled prevalence of HO of 44.6% (17.8 to 72.3%) and of advanced HO (Grade III and IV) of 11.1% (4.2 to 23.1%) after 1 year and of 58.2% (28.8% to 78.5%) and 16.7% (8.5 to 32.3%) 2 years after cTDR, respectively. Current publications tend to report higher incidences of HO with 17.8% HO 1 year after implantation of the Bryan disc (including 6.7% Grade III or IV), 34 7.9% Grade IV 2 years after Mobi-C implantation, 5 or an overall HO occurrence of 94.1%. 41 Yi et al. 57 observed an overall HO rate for 3 different cTDRs of 40.6% and Brenke et al. 10 found HO (Grade III and IV) in 17.4% after 18 months using fluoroscopy and even higher incidences using CT-based analysis. The SWISSspine registry 1 showed 13.9% of cases with Grade III and 0.9% with Grade IV HO. Alvin et al. 2 concluded from a literature review that studies with a conflict of interest (COI) reported lower HO rates after cTDR compared with those without a COI.
The mechanism of HO development in the cervical spine is not yet clear, but possible causes seem to be manifold, including preoperative degenerative processes, surgical technique, implant design, 51,57 limited motion, 33 or genetic factors, 25 and have already been discussed in an earlier publication. 51 The clinical relevance of HO is controversial, indicating that HO does not affect clinical improvement 5, 33, 38, 51, 52, 57 and is less relevant in the absence of clinical symptoms, 6, 28 while challenging the principle of motion preservation. On the other hand, most studies show that in the majority of patients segmental mobility was sustained 4 to 6 years after cTDR.
cTDR is expected to reduce the risk of ASD. Yang et al. 56 investigated the literature on ASD 4 to 6 years after cTDR in RCTs and found lower rates of degeneration and surgery in cTDR (8.8% and 3.2%, respectively) versus ACDF (13% and 4.8%, respectively), but the differences were not statistically significant. Alvin et al.
2
confirmed this for studies with a COI, but not for those without. SWISSspine 1 showed that 11.1% of patients had signs of ASD progression after 5 years, but the definition remained unclear; missing answers were counted as "no ASD." Beaurain et al. 5 reported 9.1% of cases with radiological ASD 2 years postoperatively, and Goffin et al. 22 identified 4 patients (4.1%) with procedures involving other cervical levels 4 to 6 years after cTDR. Because standardized techniques and definitions for ASD are lacking, it is difficult to make comparisons with other studies. Secondary procedure at adjacent levels, therefore, is a clearer end point.
As shown in Table 6 adjacent-level surgery after 4 to 6 years occurred within a range of 0.0% to 4.9% in the cTDR control groups and between 3.0% to 4.9% in the ACDF groups, which indicates that our study is within 4.5% of the expectations.
The results of this prospective multicenter study verify that activ C is a safe and effective device for cervical disc replacement. The literature confirms convincing results of cTDR, suggesting equivalence or superiority in some aspects when compared with ACDF. To learn more about the long-term impact of HO and potential benefits regarding adjacent segments, longer-term studies are mandatory to confirm cTDR.
Conclusions
The activ C is a safe and effective device for cervical disc replacement, confirming the encouraging results after cTDR.
acknowledgments
We thank Mrs. Nele Borm, frictionless GmbH, Kiel, Germany, 
